Shopping Cart
- Remove All
- Your shopping cart is currently empty
Topsalysin, a prostate-specific antigen (PSA)-activated protoxin, comprises a synthetic proaerolysin fusion protein targeting human prostate-specific antigen. This compound has demonstrated tumor-suppressive effects in a mouse model [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Topsalysin, a prostate-specific antigen (PSA)-activated protoxin, comprises a synthetic proaerolysin fusion protein targeting human prostate-specific antigen. This compound has demonstrated tumor-suppressive effects in a mouse model [1]. |
In vitro | Topsalysin (19 pM-10 nM; 48 hours) demonstrates PSA-dependent cytotoxicity in LNCaP, PC3, DU145, and TSU cell lines [1]. |
In vivo | Topsalysin (intra-tumoral injection; 1-10 μg/mouse; single dose) inhibits tumor growth in mice [1]. In addition, a single intraperitoneal injection of Topsalysin (0.35, 4.1, 25.8 μg/kg, 25 μL) killed up to 50% of the cells at the prostate injection site in cynomolgus monkeys [1]. |
Alias | PRX-302 |
Cas No. | 917121-25-6 |
Storage | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.